Medical Device | April 28, 2026
Stryker launches Trident II Hip System in India
New acetabular system enhances precision, stability and robotic compatibility in total hip arthroplasty
New acetabular system enhances precision, stability and robotic compatibility in total hip arthroplasty
Hyderabad based 400-bed facility brings AI-driven care, advanced imaging, and integrated clinical systems under one roof
On the generics and biosimilars front, the combined business is expected to benefit from Sun’s portfolio of more than 550 approved ANDAs across multiple dosage forms
The company has supported the initiative since its inception, contributing to screening efforts in around 120 countries
The product is manufactured at AKUMS’ state-of-the-art injectable facility in Kotdwar, Uttarakhand
The capital will be deployed to deepen AI-driven personalisation capabilities, expand its dark store network, and build a strong offline retail presence
Deploys $40 million in Hyderabad; advances APIs, peptides, and global small molecule capabilities
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
_256_384.jpg)
The approval makes Cipla’s product the first AB-rated generic therapeutic equivalent of Ventolin HFA
The deal signals a clear push to expand access to care in underserved regions
Subscribe To Our Newsletter & Stay Updated
